
Dr Kevin Kemp
B.Sc.(W.England), M.Sc.(Bristol), Ph.D.(W.England)
Current positions
Senior Lecturer in Neuroscience
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
The major aim of my research is to develop neuro-regenerative therapies for people with currently untreatable progressive neurological disease.
Cell therapies hold much promise for the treatment of human diseases. Experimental findings in both humans and models of neurodegenerative disease have shown that adult stem cells derived from the bone marrow, commonly known as bone marrow or blood stem cells, can protect or even repair injured nerve cells. Through employing experimental studies, ranging from basic neuroscience to translational clinical trials, my research explores the medical use of bone marrow stem cell transplantation and mobilisation techniques as a regenerative therapy for people with Friedreich’s ataxia and cerebellar disorders.
Publications
Recent publications
01/03/2024The bone marrow microenvironment in immune-mediated inflammatory diseases
Stem Cells Translational Medicine
An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia
Nature Communications
KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
Journal of Neurology
Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
Multiple Sclerosis Journal
Abnormal scaffold attachment factor 1 expression and localisation in spinocerebellar ataxias and huntington’s chorea
Brain Pathology